SARS-CoV-2 and COVID-19: A Narrative Review

Overview

Journal Br J Biomed Sci

Specialty Biology

Date 2022 Sep 23

PMID 36148046

Authors

A D Blann

R Heitmar

Affiliations

Soon will be listed here.

Abstract

The World Health Organisation has reported that the viral disease known as COVID-19, caused by SARS-CoV-2, is the leading cause of death by a single infectious agent. This narrative review examines certain components of the pandemic: its origins, early clinical data, global and UK-focussed epidemiology, vaccination, variants, and long COVID.

Citing Articles

A Low Number of Baselines γδ T Cells Increases the Risk of SARS-CoV-2 Post-Vaccination Infection.

Andreu-Ballester J, Galindo-Regal L, Cuellar C, Lopez-Chulia F, Garcia-Ballesteros C, Fernandez-Murga L Vaccines (Basel). 2024; 12(5).

PMID: 38793803 PMC: 11125751. DOI: 10.3390/vaccines12050553.

Crystal Structures of Fusion Cores from CCoV-HuPn-2018 and SADS-CoV.

Wang F, Yang G, Yan L Viruses. 2024; 16(2).

PMID: 38400047 PMC: 10893436. DOI: 10.3390/v16020272.

Remdesivir: treatment of COVID-19 in special populations.

Molaei E, Molaei A, Wallace Hayes A, Karimi G Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(6):3829-3855.

PMID: 38180557 DOI: 10.1007/s00210-023-02927-2.

Single-cell transcriptomic atlas of distinct early immune responses induced by SARS-CoV-2 Proto or its variants in rhesus monkey.

Yang Y, Du T, Yu W, Zhou Y, Yang C, Kuang D MedComm (2020). 2023; 4(6):e432.

PMID: 38020713 PMC: 10661830. DOI: 10.1002/mco2.432.

Modeling the XBB strain of SARS-CoV-2: Competition between variants and impact of reinfection.

Cheng Z, Lai Y, Jin K, Zhang M, Wang J J Theor Biol. 2023; 574:111611.

PMID: 37640233 PMC: 10592017. DOI: 10.1016/j.jtbi.2023.111611.

References

Dubey A, Choudhary S, Kumar P, Tomar S . Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications. Curr Microbiol. 2021; 79(1):20. PMC: 8669229. DOI: 10.1007/s00284-021-02724-1. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Capano G, Howlett M, Jarvis D, Ramesh M, Goyal N . Mobilizing Policy (In)Capacity to Fight COVID-19: Understanding Variations in State Responses. Policy Soc. 2022; 39(3):285-308. PMC: 8754710. DOI: 10.1080/14494035.2020.1787628. View

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

Bruel T, Hadjadj J, Maes P, Planas D, Seve A, Staropoli I . Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies. Nat Med. 2022; 28(6):1297-1302. DOI: 10.1038/s41591-022-01792-5. View

Bikdeli B, Madhavan M, Gupta A, Jimenez D, Burton J, Nigoghossian C . Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020; 120(7):1004-1024. PMC: 7516364. DOI: 10.1055/s-0040-1713152. View

Shimabukuro T . Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021. Am J Transplant. 2021; 21(3):1326-1331. PMC: 8013433. DOI: 10.1111/ajt.16517. View

Han Q, Zheng B, Daines L, Sheikh A . Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022; 11(2). PMC: 8875269. DOI: 10.3390/pathogens11020269. View

Jennings G, Monaghan A, Xue F, Mockler D, Romero-Ortuno R . A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome. J Clin Med. 2021; 10(24). PMC: 8708187. DOI: 10.3390/jcm10245913. View

10.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

11.

Zhang L, Jackson C, Mou H, Ojha A, Peng H, Quinlan B . SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. 2020; 11(1):6013. PMC: 7693302. DOI: 10.1038/s41467-020-19808-4. View

12.

Fonager J, Bennedbaek M, Bager P, Wohlfahrt J, Ellegaard K, Ingham A . Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022. Euro Surveill. 2022; 27(10). PMC: 8915403. DOI: 10.2807/1560-7917.ES.2022.27.10.2200181. View

13.

Huang Y, Kuan C . Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2022; 26(5):1770-1776. DOI: 10.26355/eurrev_202203_28248. View

14.

Spyropoulos A, Bonaca M . Studying the coagulopathy of COVID-19. Lancet. 2021; 399(10320):118-119. PMC: 8598181. DOI: 10.1016/S0140-6736(21)01906-1. View

15.

Chen J, Wang R, Gilby N, Wei G . Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J Chem Inf Model. 2022; 62(2):412-422. PMC: 8751645. DOI: 10.1021/acs.jcim.1c01451. View

16.

Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

17.

. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

18.

Unwin R . The 1918 Influenza Pandemic: Back to the Future?. Kidney Blood Press Res. 2021; 46(5):639-646. DOI: 10.1159/000519288. View

19.

Callaway E . Delta coronavirus variant: scientists brace for impact. Nature. 2021; 595(7865):17-18. DOI: 10.1038/d41586-021-01696-3. View

20.

Gerber G, Chaturvedi S . How to recognize and manage COVID-19-associated coagulopathy. Hematology Am Soc Hematol Educ Program. 2021; 2021(1):614-620. PMC: 8791093. DOI: 10.1182/hematology.2021000297. View